PATENT CLAIM ANALYSIS

Application Number: 15880002
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "012400"]

Abstract:
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.

Claim (Index 8):
The method of  claim 1 , wherein said composition comprises a formulation comprising one or more components selected from the group consisting of a buffering agent, an isotonicity agent, a stabilizer and an anti-adsorbent agent.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 86.0
- Lexical Diversity: 1.34043
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15225355', '12784117', '13466672', '12744079', '13336651']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7761542819158755
- 35 USC 102 Novelty (BERT): 0.5529780508588998
- Combined Prediction Score: 0.753836658810178
- Mean Citation Score: 360.427614
- Max Citation Score: 491.46228
- Similarity Product: 276.778694778378

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test